Draupnir Bio

Draupnir Bio is a Danish biotechnology company pioneering the development of oral, small molecule degraders of extracellular disease-causing proteins. They are focused on extending the potential of targeted protein degradation (TPD) to target extracellular and membrane-bound proteins, which represent a significant portion of the human proteome. Draupnir's novel technology platform utilizes lysosome receptors to effectively degrade these previously difficult-to-target proteins, opening up new possibilities for treating a wide range of diseases.

Founded in 2017 as a spin-out from Aarhus University and the Max-Planck Society, Draupnir has secured significant funding from leading European investors and has established a robust preclinical pipeline of drug candidates. They are headquartered in Copenhagen and operate a research facility in Aarhus, Denmark. Their team consists of experienced pharma and biotech industry leaders, driven by a deep commitment to scientific excellence and a desire to bring innovative therapies to patients.

Draupnir Bio is a Danish biotechnology company dedicated to developing oral, small molecule degraders of extracellular disease-causing proteins, pioneering the next frontier of targeted protein degradation (TPD). The company is leveraging the natural machinery of the lysosome to tackle proteins that have historically been difficult or impossible to target with traditional therapies. Their innovative technology platform targets lysosome receptors, enabling the development of new therapeutic approaches for complex conditions. Draupnir Bio is driven by a commitment to scientific excellence and a desire to bring innovative therapies to patients in need, ultimately revolutionizing the field of TPD.

Draupnir Bio cultivates a culture deeply rooted in scientific excellence, innovation, and patient focus. They value respect, humility, and care in their workplace, encouraging a collaborative and driven environment. They dare their team to think big and embrace scientific curiosity to improve patients' lives, reflecting their commitment to making a difference in the healthcare field.

Draupnir Bio is committed to fostering a diverse, equitable, and inclusive workplace, valuing the unique perspectives and contributions of all employees. The company actively promotes a culture of respect, humility, and care, encouraging daring thinking and a quest for scientific excellence that transcends all backgrounds. While the company website doesn't explicitly outline specific DEI initiatives or programs, its core values, "Heartfelt," "Driven," and "Daring" suggest a commitment to creating a welcoming and supportive environment where individuals feel empowered to thrive.